Key Sessions
Louis Boon, PhD
KEYNOTE: Biomarker, FIRST! IgA and its Receptor CD89
JJP Biologics
Jenny Ann Prange
Helping patients to regain control: From pre-clinical research to clinical
MUVON Therapeutics AG
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day One (13th May 2025) - CET/CEST (Cent Europe Summer, GMT+2)
keyboard_arrow_leftSearch & Filter
search
Streams
Clear
Day One (13th May 2025) - CET/CEST (Cent Europe Summer, GMT+2)
search
Streams
Clear
Showing 1 of 1 Streams
Downstream Processing
09:00 - 09:05
Chairperson Opening Remarks: Recovery & Purification
09:05 - 09:35
Approach to complying with the latest FDA guidelines on Ethylene Glycol (EG) and Diethylene Glycol (DEG)
- A Representative from BioPhorum - -, BioPhorum
09:35 - 10:05
Expediting Downstream Processing with Cutting-Edge Antibody Purification
- Sebastian Schwaminger - Associate Professor, Medical University of Graz
10:05 - 10:35
Optimizing mAb purification: A Fast, Efficient Two-Step Process
- Marian Magdy - Department Head Protein Purification, Minapharm Pharmaceuticals
Showing 1 of 1 Streams
Downstream Processing
11:20 - 11:50
Downstream Processing: Current Challenges, Recent Advances and Future Perspectives
- Fabian Vogt - Head of Laboratory, Boehringer Ingelheim
11:50 - 12:20
Bringing PrA EBA Back to the Future
- Neil Watson - Principal Scientist, UCB
Showing 1 of 1 Streams
Downstream Processing
14:25 - 14:30
Chairperson Remarks: Recovery & Purification
14:30 - 15:00
Characterisation of particulate impurities in virus drug products: current methodologies
- Patrick Garidel - Global Development CMC Biologicals, Boehringer Ingelheim
15:00 - 15:30
Advanced Bioanalytics for Comprehensive Characterization of Biotherapeutics manufacturing
- Sofia Carvalho - Senior Scientist, iBET
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Clear